HK Stock MarketDetailed Quotes

ZHONG AO HOME (01538)

Watchlist
  • 0.860
  • 0.0000.00%
Market Closed May 22 15:55 CST
734.91MMarket Cap6.77P/E (TTM)

ZHONG AO HOME (01538) Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax
8.77%150.63M
5.49%85.11M
11.04%138.48M
2.49%80.69M
-5.96%124.71M
-17.67%78.73M
-30.53%132.61M
-16.62%95.62M
-5.79%190.88M
6.06%114.68M
Profit adjustment
Interest (income) - adjustment
82.70%-1.64M
51.64%-1.12M
2.12%-9.47M
-83.80%-2.31M
-30.02%-9.68M
67.04%-1.26M
-58.83%-7.44M
-49.63%-3.82M
32.79%-4.69M
30.51%-2.55M
Attributable subsidiary (profit) loss
58.85%-1.13M
165.98%2.24M
8.45%-2.75M
-113.63%-3.4M
32.86%-3.01M
47.18%-1.59M
-11.40%-4.48M
-2.13%-3.01M
-43.19%-4.02M
-37.13%-2.95M
Impairment and provisions:
-27.52%29.78M
25.70%29.48M
-29.95%41.09M
-10.41%23.45M
8.43%58.66M
20.61%26.18M
67.46%54.1M
12.69%21.7M
41.47%32.31M
-48.95%19.26M
-Impairmen of inventory (reversal)
----
----
----
----
----
----
-200.00%-875K
---876K
--875K
----
-Impairment of trade receivables (reversal)
-25.43%15.38M
36.08%28.05M
-21.25%20.63M
21.30%20.61M
35.59%26.2M
4.40%16.99M
1.45%19.32M
--16.28M
12.10%19.04M
----
-Impairment of goodwill
----
----
----
----
----
----
--14.99M
----
----
----
-Other impairments and provisions
-29.63%14.4M
-49.75%1.43M
-36.98%20.46M
-69.10%2.84M
57.07%32.47M
45.71%9.18M
66.86%20.67M
-67.27%6.3M
111.83%12.39M
200.33%19.26M
Revaluation surplus:
-40.66%5.29M
-40.42%1.95M
42.03%8.91M
171.42%3.28M
39.32%6.27M
-79.88%1.21M
358.23%4.5M
2,877.31%6M
-299.77%-1.74M
89.87%-216K
-Fair value of investment properties (increase)
-11.12%5.29M
-29.68%1.95M
282.13%5.95M
380.28%2.78M
3,075.51%1.56M
227.59%578K
102.68%49K
90.47%-453K
-162.21%-1.83M
-1,030.14%-4.75M
-Other fair value changes
----
----
-37.20%2.96M
-20.51%500K
5.91%4.72M
-90.25%629K
5,329.27%4.45M
42.21%6.45M
-68.46%82K
271.66%4.54M
Asset sale loss (gain):
-569.96%-1.63M
24.65%450K
-107.17%-243K
-50.62%361K
141.29%3.39M
108.62%731K
-179.51%-8.21M
-28,366.67%-8.48M
811.23%10.32M
102.03%30K
-Loss (gain) from sale of subsidiary company
----
----
----
----
----
98.27%-145K
-185.22%-8.37M
---8.37M
746.12%9.82M
----
-Loss (gain) on sale of property, machinery and equipment
-457.98%-1.82M
-48.20%187K
0.31%-326K
-14.66%361K
-299.39%-327K
481.08%423K
121.84%164K
-470.00%-111K
-1,188.41%-751K
-26.83%30K
-Loss (gain) from selling other assets
130.12%191K
--263K
-97.77%83K
----
--3.72M
--453K
----
----
--1.25M
----
Depreciation and amortization:
-18.33%38.07M
-14.88%20.15M
11.26%46.61M
-3.68%23.67M
-0.50%41.9M
29.46%24.58M
-13.64%42.11M
-38.50%18.99M
-18.62%48.76M
13.26%30.87M
-Depreciation
-16.91%27.19M
-16.11%14.74M
17.93%32.72M
-3.15%17.57M
0.87%27.75M
56.35%18.14M
7.89%27.51M
-16.34%11.61M
11.18%25.5M
50.80%13.87M
-Amortization of intangible assets
-9.28%8.62M
-7.68%4.47M
-7.18%9.51M
-8.55%4.85M
-14.07%10.24M
-6.49%5.3M
-8.17%11.92M
-20.05%5.67M
-6.86%12.98M
6.72%7.09M
Financial expense
-13.56%2.05M
-0.69%865K
-12.14%2.37M
-8.41%871K
9.82%2.69M
-34.50%951K
-51.55%2.45M
-71.30%1.45M
-65.22%5.06M
-42.81%5.06M
Exchange Loss (gain)
54.64%733K
-143.82%-482K
124.97%474K
308.73%1.1M
-361.07%-1.9M
-518.25%-527K
382.88%727K
110.90%126K
87.36%-257K
15.62%-1.16M
Operating profit before the change of operating capital
-1.47%222.14M
8.57%138.65M
1.09%225.47M
-1.00%127.7M
3.08%223.04M
0.33%128.99M
-21.78%216.38M
-21.13%128.57M
-3.35%276.63M
-4.75%163.02M
Change of operating capital
Inventory (increase) decrease
269.07%4.77M
122.70%7.21M
-323.91%-2.82M
264.53%3.24M
96.89%-665K
90.39%-1.97M
-37.84%-21.37M
64.44%-20.47M
-95.34%-15.5M
-3,271.14%-57.58M
Accounts receivable (increase)decrease
-632.33%-63.03M
-64.65%-168.15M
117.32%11.84M
2.76%-102.13M
47.46%-68.37M
38.35%-105.03M
-23.39%-130.12M
23.11%-170.36M
-435.61%-105.45M
-9.40%-221.57M
Accounts payable increase (decrease)
102.14%3.77M
94.90%-2.54M
-545.64%-176.39M
-24.03%-49.82M
-52.25%39.58M
-201.96%-40.17M
250.83%82.9M
-72.66%39.4M
172.38%23.63M
834.59%144.07M
prepayments (increase)decrease
-85.95%7.88M
-99.01%130K
256.69%56.09M
449.55%13.16M
-567.69%-35.8M
-141.24%-3.76M
95.19%-5.36M
117.22%9.13M
-264.04%-111.48M
-209.83%-52.99M
Cash  from business operations
53.73%175.53M
-214.67%-24.71M
-27.64%114.19M
64.21%-7.85M
10.79%157.79M
-59.64%-21.94M
110.00%142.43M
45.15%-13.74M
-76.53%67.82M
-197.66%-25.05M
Other taxs
37.25%-34.77M
18.12%-23.26M
-64.39%-55.41M
-26.89%-28.41M
42.77%-33.71M
8.38%-22.39M
-73.28%-58.9M
-194.12%-24.44M
52.63%-33.99M
81.17%-8.31M
Net cash from operations
139.50%140.76M
-32.28%-47.97M
-52.63%58.77M
18.20%-36.26M
48.55%124.09M
-16.10%-44.33M
146.89%83.53M
-14.45%-38.18M
-84.43%33.83M
-80.65%-33.36M
Cash flow from investment activities
Interest received - investment
-82.70%1.64M
-51.41%1.12M
-2.12%9.47M
84.24%2.3M
30.02%9.68M
-26.64%1.25M
60.30%7.44M
5.71%1.7M
-17.49%4.64M
61.04%1.61M
Dividend received - investment
----
----
23.79%2.97M
----
-14.92%2.4M
----
10.58%2.82M
10.63%2.82M
16.96%2.55M
--2.55M
Sale of fixed assets
228.43%5.15M
290.00%468K
-61.05%1.57M
--120K
40.59%4.03M
----
138.75%2.87M
-9.85%2.24M
49.25%1.2M
364.18%2.49M
Purchase of fixed assets
7.62%-22.08M
7.28%-7.4M
9.04%-23.9M
47.05%-7.98M
-31.57%-26.27M
-37.73%-15.08M
59.06%-19.97M
19.78%-10.95M
-115.06%-48.77M
-123.50%-13.65M
Purchase of intangible assets
----
----
92.76%-69K
----
66.85%-953K
79.92%-48K
-12.88%-2.88M
-4,680.00%-239K
-613.45%-2.55M
98.67%-5K
Sale of subsidiaries
----
----
--2M
----
----
92.31%2.38M
149.70%1.24M
--1.24M
123.96%495K
----
Acquisition of subsidiaries
----
----
----
----
----
----
----
----
101.23%444K
101.71%444K
Recovery of cash from investments
567.71%1.28M
--1.15M
-98.82%192K
----
6,434.80%16.34M
1,460.00%3.9M
-66.67%250K
--250K
--750K
----
Cash on investment
----
----
----
----
94.89%-3.08M
----
-5,886.78%-60.23M
---19.83M
32.12%-1.01M
----
Other items in the investment business
----
----
----
22.22%11K
---2.45M
-81.25%9K
----
100.07%48K
----
-166.44%-67.71M
Net cash from investment operations
-80.37%-14M
15.98%-4.66M
-2,396.14%-7.76M
26.89%-5.55M
99.55%-311K
66.58%-7.59M
-62.06%-68.46M
69.42%-22.71M
47.67%-42.24M
-7.68%-74.27M
Net cash before financing
148.50%126.76M
-25.87%-52.63M
-58.79%51.01M
19.47%-41.81M
721.27%123.77M
14.74%-51.92M
279.18%15.07M
43.42%-60.9M
-106.16%-8.41M
-23.10%-107.63M
Cash flow from financing activities
New borrowing
-19.98%40M
-19.84%40M
-61.25%49.99M
1.86%49.9M
122.80%128.99M
-8.40%48.99M
-15.54%57.9M
0.11%53.48M
-43.81%68.55M
-41.93%53.43M
Refund
13.46%-45.92M
6.27%-45.92M
58.87%-53.06M
0.00%-48.99M
-192.83%-128.99M
-140.88%-48.99M
50.35%-44.05M
65.13%-20.34M
51.17%-88.72M
-40.36%-58.32M
Interest paid - financing
13.56%-2.05M
0.69%-865K
12.14%-2.37M
8.41%-871K
-9.82%-2.69M
21.34%-951K
31.27%-2.45M
-492.65%-1.21M
-21.56%-3.57M
85.89%-204K
Dividends paid - financing
-23.86%-31.75M
-108.14%-4.4M
24.29%-25.64M
10.61%-2.11M
-68.14%-33.86M
-157.07%-2.37M
20.79%-20.14M
95.92%-920K
25.48%-25.43M
-9.73%-22.53M
Absorb investment income
3,611.54%1.93M
-101.38%-50K
--52K
374.97%3.62M
----
-88.06%763K
-14.74%6.89M
26.28%6.39M
2,275.00%8.08M
--5.06M
Net cash from financing operations
-7.84%-39.86M
-2,321.06%-12.13M
7.92%-36.96M
114.79%546K
-743.83%-40.14M
-110.29%-3.69M
90.70%-4.76M
194.51%35.86M
49.98%-51.16M
-173.04%-37.94M
Effect of rate
-54.64%-733K
143.82%482K
-124.97%-474K
-308.73%-1.1M
361.07%1.9M
518.25%527K
-382.88%-727K
-110.90%-126K
-92.66%257K
120.61%1.16M
Net Cash
518.63%86.9M
-56.92%-64.76M
-83.20%14.05M
25.79%-41.27M
710.79%83.63M
-122.12%-55.61M
117.32%10.32M
82.80%-25.04M
-273.81%-59.57M
-310.24%-145.58M
Begining period cash
2.55%545.16M
2.55%545.16M
19.18%531.58M
19.18%531.58M
2.20%446.05M
2.20%446.05M
-11.96%436.46M
-11.96%436.46M
8.25%495.77M
8.25%495.77M
Cash at the end
15.81%631.32M
-1.70%480.88M
2.55%545.16M
25.13%489.22M
19.18%531.58M
-4.94%390.97M
2.20%446.05M
17.06%411.3M
-11.96%436.46M
-16.95%351.35M
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax 8.77%150.63M5.49%85.11M11.04%138.48M2.49%80.69M-5.96%124.71M-17.67%78.73M-30.53%132.61M-16.62%95.62M-5.79%190.88M6.06%114.68M
Profit adjustment
Interest (income) - adjustment 82.70%-1.64M51.64%-1.12M2.12%-9.47M-83.80%-2.31M-30.02%-9.68M67.04%-1.26M-58.83%-7.44M-49.63%-3.82M32.79%-4.69M30.51%-2.55M
Attributable subsidiary (profit) loss 58.85%-1.13M165.98%2.24M8.45%-2.75M-113.63%-3.4M32.86%-3.01M47.18%-1.59M-11.40%-4.48M-2.13%-3.01M-43.19%-4.02M-37.13%-2.95M
Impairment and provisions: -27.52%29.78M25.70%29.48M-29.95%41.09M-10.41%23.45M8.43%58.66M20.61%26.18M67.46%54.1M12.69%21.7M41.47%32.31M-48.95%19.26M
-Impairmen of inventory (reversal) -------------------------200.00%-875K---876K--875K----
-Impairment of trade receivables (reversal) -25.43%15.38M36.08%28.05M-21.25%20.63M21.30%20.61M35.59%26.2M4.40%16.99M1.45%19.32M--16.28M12.10%19.04M----
-Impairment of goodwill --------------------------14.99M------------
-Other impairments and provisions -29.63%14.4M-49.75%1.43M-36.98%20.46M-69.10%2.84M57.07%32.47M45.71%9.18M66.86%20.67M-67.27%6.3M111.83%12.39M200.33%19.26M
Revaluation surplus: -40.66%5.29M-40.42%1.95M42.03%8.91M171.42%3.28M39.32%6.27M-79.88%1.21M358.23%4.5M2,877.31%6M-299.77%-1.74M89.87%-216K
-Fair value of investment properties (increase) -11.12%5.29M-29.68%1.95M282.13%5.95M380.28%2.78M3,075.51%1.56M227.59%578K102.68%49K90.47%-453K-162.21%-1.83M-1,030.14%-4.75M
-Other fair value changes ---------37.20%2.96M-20.51%500K5.91%4.72M-90.25%629K5,329.27%4.45M42.21%6.45M-68.46%82K271.66%4.54M
Asset sale loss (gain): -569.96%-1.63M24.65%450K-107.17%-243K-50.62%361K141.29%3.39M108.62%731K-179.51%-8.21M-28,366.67%-8.48M811.23%10.32M102.03%30K
-Loss (gain) from sale of subsidiary company --------------------98.27%-145K-185.22%-8.37M---8.37M746.12%9.82M----
-Loss (gain) on sale of property, machinery and equipment -457.98%-1.82M-48.20%187K0.31%-326K-14.66%361K-299.39%-327K481.08%423K121.84%164K-470.00%-111K-1,188.41%-751K-26.83%30K
-Loss (gain) from selling other assets 130.12%191K--263K-97.77%83K------3.72M--453K----------1.25M----
Depreciation and amortization: -18.33%38.07M-14.88%20.15M11.26%46.61M-3.68%23.67M-0.50%41.9M29.46%24.58M-13.64%42.11M-38.50%18.99M-18.62%48.76M13.26%30.87M
-Depreciation -16.91%27.19M-16.11%14.74M17.93%32.72M-3.15%17.57M0.87%27.75M56.35%18.14M7.89%27.51M-16.34%11.61M11.18%25.5M50.80%13.87M
-Amortization of intangible assets -9.28%8.62M-7.68%4.47M-7.18%9.51M-8.55%4.85M-14.07%10.24M-6.49%5.3M-8.17%11.92M-20.05%5.67M-6.86%12.98M6.72%7.09M
Financial expense -13.56%2.05M-0.69%865K-12.14%2.37M-8.41%871K9.82%2.69M-34.50%951K-51.55%2.45M-71.30%1.45M-65.22%5.06M-42.81%5.06M
Exchange Loss (gain) 54.64%733K-143.82%-482K124.97%474K308.73%1.1M-361.07%-1.9M-518.25%-527K382.88%727K110.90%126K87.36%-257K15.62%-1.16M
Operating profit before the change of operating capital -1.47%222.14M8.57%138.65M1.09%225.47M-1.00%127.7M3.08%223.04M0.33%128.99M-21.78%216.38M-21.13%128.57M-3.35%276.63M-4.75%163.02M
Change of operating capital
Inventory (increase) decrease 269.07%4.77M122.70%7.21M-323.91%-2.82M264.53%3.24M96.89%-665K90.39%-1.97M-37.84%-21.37M64.44%-20.47M-95.34%-15.5M-3,271.14%-57.58M
Accounts receivable (increase)decrease -632.33%-63.03M-64.65%-168.15M117.32%11.84M2.76%-102.13M47.46%-68.37M38.35%-105.03M-23.39%-130.12M23.11%-170.36M-435.61%-105.45M-9.40%-221.57M
Accounts payable increase (decrease) 102.14%3.77M94.90%-2.54M-545.64%-176.39M-24.03%-49.82M-52.25%39.58M-201.96%-40.17M250.83%82.9M-72.66%39.4M172.38%23.63M834.59%144.07M
prepayments (increase)decrease -85.95%7.88M-99.01%130K256.69%56.09M449.55%13.16M-567.69%-35.8M-141.24%-3.76M95.19%-5.36M117.22%9.13M-264.04%-111.48M-209.83%-52.99M
Cash  from business operations 53.73%175.53M-214.67%-24.71M-27.64%114.19M64.21%-7.85M10.79%157.79M-59.64%-21.94M110.00%142.43M45.15%-13.74M-76.53%67.82M-197.66%-25.05M
Other taxs 37.25%-34.77M18.12%-23.26M-64.39%-55.41M-26.89%-28.41M42.77%-33.71M8.38%-22.39M-73.28%-58.9M-194.12%-24.44M52.63%-33.99M81.17%-8.31M
Net cash from operations 139.50%140.76M-32.28%-47.97M-52.63%58.77M18.20%-36.26M48.55%124.09M-16.10%-44.33M146.89%83.53M-14.45%-38.18M-84.43%33.83M-80.65%-33.36M
Cash flow from investment activities
Interest received - investment -82.70%1.64M-51.41%1.12M-2.12%9.47M84.24%2.3M30.02%9.68M-26.64%1.25M60.30%7.44M5.71%1.7M-17.49%4.64M61.04%1.61M
Dividend received - investment --------23.79%2.97M-----14.92%2.4M----10.58%2.82M10.63%2.82M16.96%2.55M--2.55M
Sale of fixed assets 228.43%5.15M290.00%468K-61.05%1.57M--120K40.59%4.03M----138.75%2.87M-9.85%2.24M49.25%1.2M364.18%2.49M
Purchase of fixed assets 7.62%-22.08M7.28%-7.4M9.04%-23.9M47.05%-7.98M-31.57%-26.27M-37.73%-15.08M59.06%-19.97M19.78%-10.95M-115.06%-48.77M-123.50%-13.65M
Purchase of intangible assets --------92.76%-69K----66.85%-953K79.92%-48K-12.88%-2.88M-4,680.00%-239K-613.45%-2.55M98.67%-5K
Sale of subsidiaries ----------2M--------92.31%2.38M149.70%1.24M--1.24M123.96%495K----
Acquisition of subsidiaries --------------------------------101.23%444K101.71%444K
Recovery of cash from investments 567.71%1.28M--1.15M-98.82%192K----6,434.80%16.34M1,460.00%3.9M-66.67%250K--250K--750K----
Cash on investment ----------------94.89%-3.08M-----5,886.78%-60.23M---19.83M32.12%-1.01M----
Other items in the investment business ------------22.22%11K---2.45M-81.25%9K----100.07%48K-----166.44%-67.71M
Net cash from investment operations -80.37%-14M15.98%-4.66M-2,396.14%-7.76M26.89%-5.55M99.55%-311K66.58%-7.59M-62.06%-68.46M69.42%-22.71M47.67%-42.24M-7.68%-74.27M
Net cash before financing 148.50%126.76M-25.87%-52.63M-58.79%51.01M19.47%-41.81M721.27%123.77M14.74%-51.92M279.18%15.07M43.42%-60.9M-106.16%-8.41M-23.10%-107.63M
Cash flow from financing activities
New borrowing -19.98%40M-19.84%40M-61.25%49.99M1.86%49.9M122.80%128.99M-8.40%48.99M-15.54%57.9M0.11%53.48M-43.81%68.55M-41.93%53.43M
Refund 13.46%-45.92M6.27%-45.92M58.87%-53.06M0.00%-48.99M-192.83%-128.99M-140.88%-48.99M50.35%-44.05M65.13%-20.34M51.17%-88.72M-40.36%-58.32M
Interest paid - financing 13.56%-2.05M0.69%-865K12.14%-2.37M8.41%-871K-9.82%-2.69M21.34%-951K31.27%-2.45M-492.65%-1.21M-21.56%-3.57M85.89%-204K
Dividends paid - financing -23.86%-31.75M-108.14%-4.4M24.29%-25.64M10.61%-2.11M-68.14%-33.86M-157.07%-2.37M20.79%-20.14M95.92%-920K25.48%-25.43M-9.73%-22.53M
Absorb investment income 3,611.54%1.93M-101.38%-50K--52K374.97%3.62M-----88.06%763K-14.74%6.89M26.28%6.39M2,275.00%8.08M--5.06M
Net cash from financing operations -7.84%-39.86M-2,321.06%-12.13M7.92%-36.96M114.79%546K-743.83%-40.14M-110.29%-3.69M90.70%-4.76M194.51%35.86M49.98%-51.16M-173.04%-37.94M
Effect of rate -54.64%-733K143.82%482K-124.97%-474K-308.73%-1.1M361.07%1.9M518.25%527K-382.88%-727K-110.90%-126K-92.66%257K120.61%1.16M
Net Cash 518.63%86.9M-56.92%-64.76M-83.20%14.05M25.79%-41.27M710.79%83.63M-122.12%-55.61M117.32%10.32M82.80%-25.04M-273.81%-59.57M-310.24%-145.58M
Begining period cash 2.55%545.16M2.55%545.16M19.18%531.58M19.18%531.58M2.20%446.05M2.20%446.05M-11.96%436.46M-11.96%436.46M8.25%495.77M8.25%495.77M
Cash at the end 15.81%631.32M-1.70%480.88M2.55%545.16M25.13%489.22M19.18%531.58M-4.94%390.97M2.20%446.05M17.06%411.3M-11.96%436.46M-16.95%351.35M
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More